Literature DB >> 34157144

Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.

Sajad Khiali1, Taher Entezari-Maleki1,2.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; acute respiratory distress syndrome (ARDS); corticosteroid; cytokine release syndrome; dexamethasone; methylprednisolone

Year:  2021        PMID： 34157144     DOI： 10.1002/jcph.1929

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  2 in total

1.  Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.

Authors:  Rafael San-Juan; Mario Fernández-Ruiz; Francisco López-Medrano; Octavio Carretero; Antonio Lalueza; Guillermo Maestro de la Calle; María Asunción Pérez-Jacoiste Asín; Héctor Bueno; José Manuel Caro-Teller; Mercedes Catalán; Cristina de la Calle; Rocío García-García; Carlos Gómez; Rocío Laguna-Goya; Manuel Lizasoáin; Joaquín Martínez-López; Julia Origüen; Ángel Sevillano; Eduardo Gutiérrez; Borja de Miguel; Fernando Aguilar; Patricia Parra; Mar Ripoll; Tamara Ruiz-Merlo; Hernando Trujillo; José Luis Pablos; Estela Paz-Artal; Carlos Lumbreras; José María Aguado
Journal:  Int J Infect Dis       Date:  2022-01-23       Impact factor: 12.074

2.  Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More.

Authors:  Seema Joshi; Zachary Smith; Sana Soman; Saniya Jain; Atheel Yako; Marwa Hojeij; Louis Massoud; Ayman Alsaadi; Jonathan Williams; Rachel Kenney; Joseph Miller; George Alangaden; Mayur Ramesh
Journal:  Open Forum Infect Dis       Date:  2021-12-08       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.